Myosteatosis is an independent risk factor for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunting.,European Journal of Gastroenterology & Hepatology

当前位置： X-MOL 学术 › Eur. Gastroenterol. Hepatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Myosteatosis is an independent risk factor for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunting.
European Journal of Gastroenterology & Hepatology ( IF 2.1 ) Pub Date : 2024-02-29 , DOI: 10.1097/meg.0000000000002729
Wenfeng Shi ₁ , Hua Yin _{1,

2} , Zhijian Yu _{1,

3} , Yong Li ₄ , Xiao Bai ₄ , Sirui Fu ₄ , Chongyang Duan ₅ , Weiguo Xu ₄ , Yang Yang ₄

Affiliation

The relationship between skeletal muscle and adipose tissue compositions and risk of overt hepatic encephalopathy (OHE) following transjugular intrahepatic portosystemic shunt (TIPS) treatment needs to be investigated.

中文翻译：